Ms. Rea, MSPH, is an independent consultant providing regulatory-related services for organizations developing small molecule and biologic drugs, vaccines and gene therapy products. Her industrial career has spanned over 40 years, from development through commercialization with increasing levels of responsibility and scope in the areas of oncology and rare diseases with a variety of modalities, including gene and cellular therapies; rDNA biologics, biosimilars and small-molecule drugs. She most recently worked for AVM Biotechnology and Atossa Therapeutics. Companies for whom she has worked include Immunex (Amgen), MDS Panlabs, Targeted Genetics, AVI Biopharma (Sarepta) and Protein Sciences Corp (Sanofi), and a number of other companies as a consultant. She was also an Assistant Clinical Professor for the University of Washington in the Department of Pharmacy.
A trained microbiologist, she received her Bachelors of Science degree in microbiology from the University of Washington, and was conferred a Masters of Science of Public Health from the same institution.